Literature DB >> 22891280

Upstream stimulating factors regulate the expression of RORγT in human lymphocytes.

Marcin Ratajewski1, Aurelia Walczak-Drzewiecka, Anna Salkowska, Jaroslaw Dastych.   

Abstract

Retinoic acid-related orphan receptor γT (RORγT) is the orphan nuclear receptor that regulates the development of Th17 cells and the expression of IL-17. The differentiation of Th17 cells is associated with the upregulation of RORγT mRNA, and the mechanisms regulating that process in human cells are not well understood. We investigated the transcriptional regulation of RORγT in a human lymphocytic cell line and Th17 differentiated from naive CD4+ cells from human peripheral blood. A series of experiments, including 5' deletion and in situ mutagenesis analysis of the human RORγT promoter, chromatin immunoprecipitation, and overexpression of selected transcription factors, revealed that the transcription factors upstream stimulatory factor 1 (USF-1) and USF-2 are indispensable for the transcription of RORγT in human lymphocytes. There was also upregulation of USF-1 and USF-2 during the differentiation of Th17 cells from naive CD4+ cells. In this article, we report the first analysis, to our knowledge, of the human RORγT promoter and demonstrate the role of the USF-1 and USF-2 transcription factors in regulating the expression of RORγT in human lymphocytes. Thus, USFs are important for the molecular mechanisms of Th17 differentiation, and possible changes in the expression of USFs might be of interest for inflammatory conditions with a Th17 component. Furthermore, these observations suggest a possible link between metabolic disorders in which the role of glucose-induced USF expression has already been established and autoimmune diseases in which the upregulation of RORγT is frequently detected.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891280     DOI: 10.4049/jimmunol.1200519

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.

Authors:  Zhiheng He; Fei Wang; Jian Ma; Subha Sen; Jing Zhang; Yousang Gwack; Yu Zhou; Zuoming Sun
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

2.  PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5.

Authors:  Subha Sen; Zhiheng He; Shubhamoy Ghosh; Kenneth J Dery; Lu Yang; Jing Zhang; Zuoming Sun
Journal:  J Immunol       Date:  2018-05-23       Impact factor: 5.422

3.  CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.

Authors:  Brian C Betts; Elizabeth M Sagatys; Anandharaman Veerapathran; Mark C Lloyd; Francisca Beato; Harshani R Lawrence; Binglin Yue; Jongphil Kim; Said M Sebti; Claudio Anasetti; Joseph Pidala
Journal:  J Leukoc Biol       Date:  2015-02-06       Impact factor: 4.962

4.  The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor γt (RORγt) in Th17 cells.

Authors:  Lei Han; Jing Yang; Xiuwen Wang; Qingsi Wu; Shuying Yin; Zhiyuan Li; Jing Zhang; Yue Xing; Zuojia Chen; Andy Tsun; Dan Li; Miranda Piccioni; Yu Zhang; Qiang Guo; Lindi Jiang; Liming Bao; Ling Lv; Bin Li
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

5.  Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer.

Authors:  John D Merriman; Bradley E Aouizerat; Janine K Cataldo; Laura Dunn; Bruce A Cooper; Claudia West; Steven M Paul; Christina R Baggott; Anand Dhruva; Kord Kober; Dale J Langford; Heather Leutwyler; Christine S Ritchie; Gary Abrams; Marylin Dodd; Charles Elboim; Deborah Hamolsky; Michelle Melisko; Christine Miaskowski
Journal:  Cytokine       Date:  2013-12-04       Impact factor: 3.861

6.  A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets.

Authors:  Steven D Scoville; Bethany L Mundy-Bosse; Michael H Zhang; Li Chen; Xiaoli Zhang; Karen A Keller; Tiffany Hughes; Luxi Chen; Stephanie Cheng; Stephen M Bergin; Hsiaoyin C Mao; Susan McClory; Jianhua Yu; William E Carson; Michael A Caligiuri; Aharon G Freud
Journal:  Immunity       Date:  2016-05-10       Impact factor: 31.745

7.  Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17, RORγt, IL4 and GATA3 gene expressions in rheumatoid arthritis patients.

Authors:  Anis Barati; Ahmad Reza Jamshidi; Hossein Ahmadi; Zahra Aghazadeh; Abbas Mirshafiey
Journal:  Drug Des Devel Ther       Date:  2017-03-30       Impact factor: 4.162

8.  The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.

Authors:  Yi-Ching Lin; Yu-Chih Lin; Cheng-Chin Wu; Ming-Yii Huang; Wen-Chan Tsai; Chih-Hsing Hung; Po-Lin Kuo
Journal:  Oncotarget       Date:  2017-01-31

9.  NFAT primes the human RORC locus for RORγt expression in CD4+ T cells.

Authors:  Hanane Yahia-Cherbal; Magda Rybczynska; Domenica Lovecchio; Tharshana Stephen; Chloé Lescale; Katarzyna Placek; Jérome Larghero; Lars Rogge; Elisabetta Bianchi
Journal:  Nat Commun       Date:  2019-10-16       Impact factor: 14.919

10.  Functional Analysis of the rs774872314, rs116171003, rs200231898 and rs201107751 Polymorphisms in the Human RORγT Gene Promoter Region.

Authors:  Marcin Ratajewski; Marcin Słomka; Kaja Karaś; Marta Sobalska-Kwapis; Małgorzata Korycka-Machała; Anna Sałkowska; Jarosław Dziadek; Dominik Strapagiel; Jarosław Dastych
Journal:  Genes (Basel)       Date:  2017-04-21       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.